Johnson & Johnson (JNJ)

164.21
0.40 0.24
NYSE
Prev Close 163.81
Open 164.61
Day Low/High 164.24 / 165.98
52 Wk Low/High 133.65 / 179.92
Volume 6.04M
Exchange NYSE
Shares Outstanding 2632.48B
Market Cap 433.70B
P/E Ratio 28.74
Div & Yield N.A. (N.A)

Latest News

An Options Play on J&J

An Options Play on J&J

Johnson & Johnson's selloff seems to be losing some steam here.

Market Fatigue, Treasuries Death Cross, Meme Memo, Taiwan Semi, Oh What a Night

Market Fatigue, Treasuries Death Cross, Meme Memo, Taiwan Semi, Oh What a Night

I could be wrong, but as far as I can tell, nobody else is telling the story about the sudden movement in these yields.

Comirnaty, Semiconductor-Palooza, Infrastructure Snag, Trading Cybersecurity

Comirnaty, Semiconductor-Palooza, Infrastructure Snag, Trading Cybersecurity

The fiscal football remains a greater threat this week than anything Fed Chair Jerome Powell says on Zoom this Friday.

Henri, Fiscal and Monetary Uncertainty, Vaccine Update, Trading Nvidia and AMD

Henri, Fiscal and Monetary Uncertainty, Vaccine Update, Trading Nvidia and AMD

Investors come into this week with 'all eyes' on the Kansas City Fed's economic symposium come week's end.

Pfizer's Charts Suggest a Strong Rally Ahead

Pfizer's Charts Suggest a Strong Rally Ahead

Here are our latest price targets.

Look No Further Than AbbVie If You Need a Defensive/Dividend Type Name

  AbbVie has been a Sarge fave for a long time. Sarge has been rewarded for trusting this firm's management when they acquired Allergan as a means toward replacing expected reductions in cash flows moving forward as the firm's patents for winder dru...

Jim Cramer: The Drug Cos. Are at Full Strength

Jim Cramer: The Drug Cos. Are at Full Strength

We're seeing a group move in pharma right now, so let's sort it out, pill by pill.

Resilience? Stagflation Signs, Nvidia Action, Fed Hawks on Deck, Booster Rockets

Resilience? Stagflation Signs, Nvidia Action, Fed Hawks on Deck, Booster Rockets

A wall of liquidity seems to absorb every dip. But there are also enough reasons to be ever vigilant.

Jim Cramer: To Every Market Sector, Turn, Turn, Turn

Jim Cramer: To Every Market Sector, Turn, Turn, Turn

To the melody of the Byrds' famed song, I want you to know: There's a time to buy the industrials, a time to sell the banks; a time to bid for health cares, a time to dump the techs. ...

Economic Growth? Trading Volume, OPEC+ Production, Vaccine Booster

Economic Growth? Trading Volume, OPEC+ Production, Vaccine Booster

These guys are aware that the U.S. was energy independent less than a year and a half ago, right?

Bond Yields, Infrastructure Bill, Job Creation, Earnings, Vaccine Booster Shots

Bond Yields, Infrastructure Bill, Job Creation, Earnings, Vaccine Booster Shots

One thing we know is that the current wave of the pandemic just seems to be getting worse.

Wednesday's Woes, Market Blame Game, Robinhood Goes Bananas, Scary Delta Math

Wednesday's Woes, Market Blame Game, Robinhood Goes Bananas, Scary Delta Math

Imagine if the SEC did not prohibit underwriters from lending out shares to short-sellers for 30 days after an IPO?

Green Tuesday, Delta Economy, Policing Cryptos, Lockheed vs General Dynamics

Green Tuesday, Delta Economy, Policing Cryptos, Lockheed vs General Dynamics

The Delta virus has more power to control both fiscal and monetary policy than does the data or do any of our leaders individually.

Biden's Spending Plan, Market Rally, Trading Nvidia, Netflix, Chipotle

Biden's Spending Plan, Market Rally, Trading Nvidia, Netflix, Chipotle

Also, there's reason to turn J&J's one shot jab into a two shot vaccine just like the rest.

Johnson & Johnson

Break in! sold off just now on this tweet: *FDA EXPECTED TO ANNOUNCE NEW WARNING ON J&J COVID VACCINE: WAPO This should help with the vaccine uptake — zerohedge (@zerohedge) July 12, 2021

Jim Cramer: I Warned You That Betting Against Science Is a Mug's Game

Jim Cramer: I Warned You That Betting Against Science Is a Mug's Game

And I was right, and the cynics were wrong. Here's why that matters more than ever now.

The Johnson & Johnson Charts Are Healthy Enough for Further Gains

The Johnson & Johnson Charts Are Healthy Enough for Further Gains

Here's where traders could probe the long side of JNJ.

If a COVID Vaccine Becomes Seasonal, Watch Novavax: Here's 2 Ways to Trade It

If a COVID Vaccine Becomes Seasonal, Watch Novavax: Here's 2 Ways to Trade It

I prefer the bear put spread over the covered equity play due to the decreased risk to principal, despite the capped potential for profit.

A Mild and Mixed Market Favors Speculative Small-Caps

A Mild and Mixed Market Favors Speculative Small-Caps

Probably the best news right now is that individual stock picking has improved.

This Dividend Aristocrat Should Put Your Portfolio on the Mend

This Dividend Aristocrat Should Put Your Portfolio on the Mend

High-quality drugmaker AbbVie has several promising products aside from Humira and the market has priced the stock at a bargain.

Moderna Could Provide a 'Shot in the Arm' for Your Portfolio

Moderna Could Provide a 'Shot in the Arm' for Your Portfolio

Debt-free and poised to gain from its COVID-19 vaccine demand, MRNA could inject some life into your investment plan.

Best Stocks With DRIP Plans Right Now

Best Stocks With DRIP Plans Right Now

These Dividend Aristocrats have free DRIPs, long histories of raising their dividends, and attractive yields well above the market average.

A Market Unmasked, Sectors Go Green, Treading Nasdaq Turf With Care

A Market Unmasked, Sectors Go Green, Treading Nasdaq Turf With Care

The market seems to rejoice from the latest mask utterance out of the CDC, but the action at the Nasdaq should give traders pause.

In the Midst of This Pandemic, Arcturus Therapeutics Has Its Lightbulb Moment

In the Midst of This Pandemic, Arcturus Therapeutics Has Its Lightbulb Moment

ARCT's IP is incredibly valuable, and may in fact be invaluable.

Welcome to the Show, Trading FedEx and UPS, Vaccine Cavalry, Pfizer's Moment?

Welcome to the Show, Trading FedEx and UPS, Vaccine Cavalry, Pfizer's Moment?

UPS and FDX are both in serious rally mode, yet in very different places in terms of technical development.

Jim Cramer: Secular Growth Is What Lam Research Is All About

Jim Cramer: Secular Growth Is What Lam Research Is All About

When you hear about chip shortage you need to think of Lam. The world needs Lam to add to capacity as fast as possible.

Get Alpha From Delta

Get Alpha From Delta

I'm seeing some attractive plays among the airlines.